 | • レポートコード：MRC2-11QY04444 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は放射免疫療法のグローバル市場について調査・分析したレポートです。種類別（非ホジキンリンパ腫（NHL）、濾胞性リンパ腫、固形腫瘍、乳がん、卵巣がん、骨肉腫、神経芽細胞腫、前立腺がん）市場規模、用途別（腫瘍抗原、放射性核種、抗体）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別放射免疫療法の競争状況、市場シェア ・世界の放射免疫療法市場：種類別市場規模 2015年-2020年（非ホジキンリンパ腫（NHL）、濾胞性リンパ腫、固形腫瘍、乳がん、卵巣がん、骨肉腫、神経芽細胞腫、前立腺がん） ・世界の放射免疫療法市場：種類別市場規模予測 2021年-2026年（非ホジキンリンパ腫（NHL）、濾胞性リンパ腫、固形腫瘍、乳がん、卵巣がん、骨肉腫、神経芽細胞腫、前立腺がん） ・世界の放射免疫療法市場：用途別市場規模 2015年-2020年（腫瘍抗原、放射性核種、抗体） ・世界の放射免疫療法市場：用途別市場規模予測 2021年-2026年（腫瘍抗原、放射性核種、抗体） ・北米の放射免疫療法市場分析：米国、カナダ ・ヨーロッパの放射免疫療法市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの放射免疫療法市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の放射免疫療法市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの放射免疫療法市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Bayer Healthcare Pharmaceuticals、BioSynthema、Clarity Pharmaceuticals、Curasight、Endocyte、Immunomedics、Molecular Insight Pharmaceuticals、Nordic Nanovector、PDL Biopharma、Philogen、RadioMedix、Stella Pharma、Telix Pharmaceuticals ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Radioimmunotherapy Market
The global Radioimmunotherapy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Radioimmunotherapy Scope and Market Size
Radioimmunotherapy market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Radioimmunotherapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Bayer Healthcare Pharmaceuticals
BioSynthema
Clarity Pharmaceuticals
Curasight
Endocyte
Immunomedics
Molecular Insight Pharmaceuticals
Nordic Nanovector
PDL Biopharma
Philogen
RadioMedix
Stella Pharma
Telix Pharmaceuticals
Market segment by Type, the product can be split into
Non Hodgkin Lymphoma (NHL)
Follicular Lymphoma
Solid Tumors
Breast Cancer
Ovarian Cancer
Osteosarcoma
Neuroblastoma
Prostate Cancer
Market segment by Application, split into
Tumor Antigens
Radionuclides
Antibodies
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Radioimmunotherapy Revenue
1.4 Market by Type
1.4.1 Global Radioimmunotherapy Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Non Hodgkin Lymphoma (NHL)
1.4.3 Follicular Lymphoma
1.4.4 Solid Tumors
1.4.5 Breast Cancer
1.4.6 Ovarian Cancer
1.4.7 Osteosarcoma
1.4.8 Neuroblastoma
1.4.9 Prostate Cancer
1.5 Market by Application
1.5.1 Global Radioimmunotherapy Market Share by Application: 2020 VS 2026
1.5.2 Tumor Antigens
1.5.3 Radionuclides
1.5.4 Antibodies
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Radioimmunotherapy Market Perspective (2015-2026)
2.2 Global Radioimmunotherapy Growth Trends by Regions
2.2.1 Radioimmunotherapy Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Radioimmunotherapy Historic Market Share by Regions (2015-2020)
2.2.3 Radioimmunotherapy Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Radioimmunotherapy Market Growth Strategy
2.3.6 Primary Interviews with Key Radioimmunotherapy Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Radioimmunotherapy Players by Market Size
3.1.1 Global Top Radioimmunotherapy Players by Revenue (2015-2020)
3.1.2 Global Radioimmunotherapy Revenue Market Share by Players (2015-2020)
3.1.3 Global Radioimmunotherapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Radioimmunotherapy Market Concentration Ratio
3.2.1 Global Radioimmunotherapy Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Radioimmunotherapy Revenue in 2019
3.3 Radioimmunotherapy Key Players Head office and Area Served
3.4 Key Players Radioimmunotherapy Product Solution and Service
3.5 Date of Enter into Radioimmunotherapy Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Radioimmunotherapy Historic Market Size by Type (2015-2020)
4.2 Global Radioimmunotherapy Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Radioimmunotherapy Market Size by Application (2015-2020)
5.2 Global Radioimmunotherapy Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Radioimmunotherapy Market Size (2015-2020)
6.2 Radioimmunotherapy Key Players in North America (2019-2020)
6.3 North America Radioimmunotherapy Market Size by Type (2015-2020)
6.4 North America Radioimmunotherapy Market Size by Application (2015-2020)
7 Europe
7.1 Europe Radioimmunotherapy Market Size (2015-2020)
7.2 Radioimmunotherapy Key Players in Europe (2019-2020)
7.3 Europe Radioimmunotherapy Market Size by Type (2015-2020)
7.4 Europe Radioimmunotherapy Market Size by Application (2015-2020)
8 China
8.1 China Radioimmunotherapy Market Size (2015-2020)
8.2 Radioimmunotherapy Key Players in China (2019-2020)
8.3 China Radioimmunotherapy Market Size by Type (2015-2020)
8.4 China Radioimmunotherapy Market Size by Application (2015-2020)
9 Japan
9.1 Japan Radioimmunotherapy Market Size (2015-2020)
9.2 Radioimmunotherapy Key Players in Japan (2019-2020)
9.3 Japan Radioimmunotherapy Market Size by Type (2015-2020)
9.4 Japan Radioimmunotherapy Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Radioimmunotherapy Market Size (2015-2020)
10.2 Radioimmunotherapy Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Radioimmunotherapy Market Size by Type (2015-2020)
10.4 Southeast Asia Radioimmunotherapy Market Size by Application (2015-2020)
11 India
11.1 India Radioimmunotherapy Market Size (2015-2020)
11.2 Radioimmunotherapy Key Players in India (2019-2020)
11.3 India Radioimmunotherapy Market Size by Type (2015-2020)
11.4 India Radioimmunotherapy Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Radioimmunotherapy Market Size (2015-2020)
12.2 Radioimmunotherapy Key Players in Central & South America (2019-2020)
12.3 Central & South America Radioimmunotherapy Market Size by Type (2015-2020)
12.4 Central & South America Radioimmunotherapy Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Bayer Healthcare Pharmaceuticals
13.1.1 Bayer Healthcare Pharmaceuticals Company Details
13.1.2 Bayer Healthcare Pharmaceuticals Business Overview
13.1.3 Bayer Healthcare Pharmaceuticals Radioimmunotherapy Introduction
13.1.4 Bayer Healthcare Pharmaceuticals Revenue in Radioimmunotherapy Business (2015-2020))
13.1.5 Bayer Healthcare Pharmaceuticals Recent Development
13.2 BioSynthema
13.2.1 BioSynthema Company Details
13.2.2 BioSynthema Business Overview
13.2.3 BioSynthema Radioimmunotherapy Introduction
13.2.4 BioSynthema Revenue in Radioimmunotherapy Business (2015-2020)
13.2.5 BioSynthema Recent Development
13.3 Clarity Pharmaceuticals
13.3.1 Clarity Pharmaceuticals Company Details
13.3.2 Clarity Pharmaceuticals Business Overview
13.3.3 Clarity Pharmaceuticals Radioimmunotherapy Introduction
13.3.4 Clarity Pharmaceuticals Revenue in Radioimmunotherapy Business (2015-2020)
13.3.5 Clarity Pharmaceuticals Recent Development
13.4 Curasight
13.4.1 Curasight Company Details
13.4.2 Curasight Business Overview
13.4.3 Curasight Radioimmunotherapy Introduction
13.4.4 Curasight Revenue in Radioimmunotherapy Business (2015-2020)
13.4.5 Curasight Recent Development
13.5 Endocyte
13.5.1 Endocyte Company Details
13.5.2 Endocyte Business Overview
13.5.3 Endocyte Radioimmunotherapy Introduction
13.5.4 Endocyte Revenue in Radioimmunotherapy Business (2015-2020)
13.5.5 Endocyte Recent Development
13.6 Immunomedics
13.6.1 Immunomedics Company Details
13.6.2 Immunomedics Business Overview
13.6.3 Immunomedics Radioimmunotherapy Introduction
13.6.4 Immunomedics Revenue in Radioimmunotherapy Business (2015-2020)
13.6.5 Immunomedics Recent Development
13.7 Molecular Insight Pharmaceuticals
13.7.1 Molecular Insight Pharmaceuticals Company Details
13.7.2 Molecular Insight Pharmaceuticals Business Overview
13.7.3 Molecular Insight Pharmaceuticals Radioimmunotherapy Introduction
13.7.4 Molecular Insight Pharmaceuticals Revenue in Radioimmunotherapy Business (2015-2020)
13.7.5 Molecular Insight Pharmaceuticals Recent Development
13.8 Nordic Nanovector
13.8.1 Nordic Nanovector Company Details
13.8.2 Nordic Nanovector Business Overview
13.8.3 Nordic Nanovector Radioimmunotherapy Introduction
13.8.4 Nordic Nanovector Revenue in Radioimmunotherapy Business (2015-2020)
13.8.5 Nordic Nanovector Recent Development
13.9 PDL Biopharma
13.9.1 PDL Biopharma Company Details
13.9.2 PDL Biopharma Business Overview
13.9.3 PDL Biopharma Radioimmunotherapy Introduction
13.9.4 PDL Biopharma Revenue in Radioimmunotherapy Business (2015-2020)
13.9.5 PDL Biopharma Recent Development
13.10 Philogen
13.10.1 Philogen Company Details
13.10.2 Philogen Business Overview
13.10.3 Philogen Radioimmunotherapy Introduction
13.10.4 Philogen Revenue in Radioimmunotherapy Business (2015-2020)
13.10.5 Philogen Recent Development
13.11 RadioMedix
10.11.1 RadioMedix Company Details
10.11.2 RadioMedix Business Overview
10.11.3 RadioMedix Radioimmunotherapy Introduction
10.11.4 RadioMedix Revenue in Radioimmunotherapy Business (2015-2020)
10.11.5 RadioMedix Recent Development
13.12 Stella Pharma
10.12.1 Stella Pharma Company Details
10.12.2 Stella Pharma Business Overview
10.12.3 Stella Pharma Radioimmunotherapy Introduction
10.12.4 Stella Pharma Revenue in Radioimmunotherapy Business (2015-2020)
10.12.5 Stella Pharma Recent Development
13.13 Telix Pharmaceuticals
10.13.1 Telix Pharmaceuticals Company Details
10.13.2 Telix Pharmaceuticals Business Overview
10.13.3 Telix Pharmaceuticals Radioimmunotherapy Introduction
10.13.4 Telix Pharmaceuticals Revenue in Radioimmunotherapy Business (2015-2020)
10.13.5 Telix Pharmaceuticals Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Radioimmunotherapy Key Market Segments
Table 2. Key Players Covered: Ranking by Radioimmunotherapy Revenue
Table 3. Ranking of Global Top Radioimmunotherapy Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Radioimmunotherapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Non Hodgkin Lymphoma (NHL)
Table 6. Key Players of Follicular Lymphoma
Table 7. Key Players of Solid Tumors
Table 8. Key Players of Breast Cancer
Table 9. Key Players of Ovarian Cancer
Table 10. Key Players of Osteosarcoma
Table 11. Key Players of Neuroblastoma
Table 12. Key Players of Prostate Cancer
Table 13. Global Radioimmunotherapy Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Radioimmunotherapy Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Radioimmunotherapy Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Radioimmunotherapy Market Share by Regions (2015-2020)
Table 17. Global Radioimmunotherapy Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Radioimmunotherapy Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Radioimmunotherapy Market Growth Strategy
Table 23. Main Points Interviewed from Key Radioimmunotherapy Players
Table 24. Global Radioimmunotherapy Revenue by Players (2015-2020) (Million US$)
Table 25. Global Radioimmunotherapy Market Share by Players (2015-2020)
Table 26. Global Top Radioimmunotherapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Radioimmunotherapy as of 2019)
Table 27. Global Radioimmunotherapy by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Radioimmunotherapy Product Solution and Service
Table 30. Date of Enter into Radioimmunotherapy Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Radioimmunotherapy Market Size by Type (2015-2020) (Million US$)
Table 33. Global Radioimmunotherapy Market Size Share by Type (2015-2020)
Table 34. Global Radioimmunotherapy Revenue Market Share by Type (2021-2026)
Table 35. Global Radioimmunotherapy Market Size Share by Application (2015-2020)
Table 36. Global Radioimmunotherapy Market Size by Application (2015-2020) (Million US$)
Table 37. Global Radioimmunotherapy Market Size Share by Application (2021-2026)
Table 38. North America Key Players Radioimmunotherapy Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Radioimmunotherapy Market Share (2019-2020)
Table 40. North America Radioimmunotherapy Market Size by Type (2015-2020) (Million US$)
Table 41. North America Radioimmunotherapy Market Share by Type (2015-2020)
Table 42. North America Radioimmunotherapy Market Size by Application (2015-2020) (Million US$)
Table 43. North America Radioimmunotherapy Market Share by Application (2015-2020)
Table 44. Europe Key Players Radioimmunotherapy Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Radioimmunotherapy Market Share (2019-2020)
Table 46. Europe Radioimmunotherapy Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Radioimmunotherapy Market Share by Type (2015-2020)
Table 48. Europe Radioimmunotherapy Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Radioimmunotherapy Market Share by Application (2015-2020)
Table 50. China Key Players Radioimmunotherapy Revenue (2019-2020) (Million US$)
Table 51. China Key Players Radioimmunotherapy Market Share (2019-2020)
Table 52. China Radioimmunotherapy Market Size by Type (2015-2020) (Million US$)
Table 53. China Radioimmunotherapy Market Share by Type (2015-2020)
Table 54. China Radioimmunotherapy Market Size by Application (2015-2020) (Million US$)
Table 55. China Radioimmunotherapy Market Share by Application (2015-2020)
Table 56. Japan Key Players Radioimmunotherapy Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Radioimmunotherapy Market Share (2019-2020)
Table 58. Japan Radioimmunotherapy Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Radioimmunotherapy Market Share by Type (2015-2020)
Table 60. Japan Radioimmunotherapy Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Radioimmunotherapy Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Radioimmunotherapy Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Radioimmunotherapy Market Share (2019-2020)
Table 64. Southeast Asia Radioimmunotherapy Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Radioimmunotherapy Market Share by Type (2015-2020)
Table 66. Southeast Asia Radioimmunotherapy Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Radioimmunotherapy Market Share by Application (2015-2020)
Table 68. India Key Players Radioimmunotherapy Revenue (2019-2020) (Million US$)
Table 69. India Key Players Radioimmunotherapy Market Share (2019-2020)
Table 70. India Radioimmunotherapy Market Size by Type (2015-2020) (Million US$)
Table 71. India Radioimmunotherapy Market Share by Type (2015-2020)
Table 72. India Radioimmunotherapy Market Size by Application (2015-2020) (Million US$)
Table 73. India Radioimmunotherapy Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Radioimmunotherapy Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Radioimmunotherapy Market Share (2019-2020)
Table 76. Central & South America Radioimmunotherapy Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Radioimmunotherapy Market Share by Type (2015-2020)
Table 78. Central & South America Radioimmunotherapy Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Radioimmunotherapy Market Share by Application (2015-2020)
Table 80. Bayer Healthcare Pharmaceuticals Company Details
Table 81. Bayer Healthcare Pharmaceuticals Business Overview
Table 82. Bayer Healthcare Pharmaceuticals Product
Table 83. Bayer Healthcare Pharmaceuticals Revenue in Radioimmunotherapy Business (2015-2020) (Million US$)
Table 84. Bayer Healthcare Pharmaceuticals Recent Development
Table 85. BioSynthema Company Details
Table 86. BioSynthema Business Overview
Table 87. BioSynthema Product
Table 88. BioSynthema Revenue in Radioimmunotherapy Business (2015-2020) (Million US$)
Table 89. BioSynthema Recent Development
Table 90. Clarity Pharmaceuticals Company Details
Table 91. Clarity Pharmaceuticals Business Overview
Table 92. Clarity Pharmaceuticals Product
Table 93. Clarity Pharmaceuticals Revenue in Radioimmunotherapy Business (2015-2020) (Million US$)
Table 94. Clarity Pharmaceuticals Recent Development
Table 95. Curasight Company Details
Table 96. Curasight Business Overview
Table 97. Curasight Product
Table 98. Curasight Revenue in Radioimmunotherapy Business (2015-2020) (Million US$)
Table 99. Curasight Recent Development
Table 100. Endocyte Company Details
Table 101. Endocyte Business Overview
Table 102. Endocyte Product
Table 103. Endocyte Revenue in Radioimmunotherapy Business (2015-2020) (Million US$)
Table 104. Endocyte Recent Development
Table 105. Immunomedics Company Details
Table 106. Immunomedics Business Overview
Table 107. Immunomedics Product
Table 108. Immunomedics Revenue in Radioimmunotherapy Business (2015-2020) (Million US$)
Table 109. Immunomedics Recent Development
Table 110. Molecular Insight Pharmaceuticals Company Details
Table 111. Molecular Insight Pharmaceuticals Business Overview
Table 112. Molecular Insight Pharmaceuticals Product
Table 113. Molecular Insight Pharmaceuticals Revenue in Radioimmunotherapy Business (2015-2020) (Million US$)
Table 114. Molecular Insight Pharmaceuticals Recent Development
Table 115. Nordic Nanovector Business Overview
Table 116. Nordic Nanovector Product
Table 117. Nordic Nanovector Company Details
Table 118. Nordic Nanovector Revenue in Radioimmunotherapy Business (2015-2020) (Million US$)
Table 119. Nordic Nanovector Recent Development
Table 120. PDL Biopharma Company Details
Table 121. PDL Biopharma Business Overview
Table 122. PDL Biopharma Product
Table 123. PDL Biopharma Revenue in Radioimmunotherapy Business (2015-2020) (Million US$)
Table 124. PDL Biopharma Recent Development
Table 125. Philogen Company Details
Table 126. Philogen Business Overview
Table 127. Philogen Product
Table 128. Philogen Revenue in Radioimmunotherapy Business (2015-2020) (Million US$)
Table 129. Philogen Recent Development
Table 130. RadioMedix Company Details
Table 131. RadioMedix Business Overview
Table 132. RadioMedix Product
Table 133. RadioMedix Revenue in Radioimmunotherapy Business (2015-2020) (Million US$)
Table 134. RadioMedix Recent Development
Table 135. Stella Pharma Company Details
Table 136. Stella Pharma Business Overview
Table 137. Stella Pharma Product
Table 138. Stella Pharma Revenue in Radioimmunotherapy Business (2015-2020) (Million US$)
Table 139. Stella Pharma Recent Development
Table 140. Telix Pharmaceuticals Company Details
Table 141. Telix Pharmaceuticals Business Overview
Table 142. Telix Pharmaceuticals Product
Table 143. Telix Pharmaceuticals Revenue in Radioimmunotherapy Business (2015-2020) (Million US$)
Table 144. Telix Pharmaceuticals Recent Development
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Radioimmunotherapy Market Share by Type: 2020 VS 2026
Figure 2. Non Hodgkin Lymphoma (NHL) Features
Figure 3. Follicular Lymphoma Features
Figure 4. Solid Tumors Features
Figure 5. Breast Cancer Features
Figure 6. Ovarian Cancer Features
Figure 7. Osteosarcoma Features
Figure 8. Neuroblastoma Features
Figure 9. Prostate Cancer Features
Figure 10. Global Radioimmunotherapy Market Share by Application: 2020 VS 2026
Figure 11. Tumor Antigens Case Studies
Figure 12. Radionuclides Case Studies
Figure 13. Antibodies Case Studies
Figure 14. Radioimmunotherapy Report Years Considered
Figure 15. Global Radioimmunotherapy Market Size YoY Growth 2015-2026 (US$ Million)
Figure 16. Global Radioimmunotherapy Market Share by Regions: 2020 VS 2026
Figure 17. Global Radioimmunotherapy Market Share by Regions (2021-2026)
Figure 18. Porter's Five Forces Analysis
Figure 19. Global Radioimmunotherapy Market Share by Players in 2019
Figure 20. Global Top Radioimmunotherapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Radioimmunotherapy as of 2019
Figure 21. The Top 10 and 5 Players Market Share by Radioimmunotherapy Revenue in 2019
Figure 22. North America Radioimmunotherapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Europe Radioimmunotherapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. China Radioimmunotherapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Japan Radioimmunotherapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Southeast Asia Radioimmunotherapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. India Radioimmunotherapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Central & South America Radioimmunotherapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. Bottom-up and Top-down Approaches for This Report
Figure 30. Data Triangulation
Figure 31. Key Executives Interviewed
非ホジキンリンパ腫（NHL）の世界市場（～2026年） Non-Hodgkin Lymphoma is the most common lymphoma which affects large number of people. It begins in lymphocytes present in lymph nodes of body parts such as neck or chest or under the arms. It widely spreads to the other lymph nodes and to other organs such as bone marrow, lungs, or liver. Market An…- ホジキンリンパ腫治療薬の世界市場（～2026年） Hodgkin's Lymphoma (HL) is defined as the cancer of the lymph tissue, which is part of our immune system. The exact etiology of HL is unknown. However, the risk of developing the condition is increased if a person suffers from a medical condition that weakens the immune system. In HL, cells in the l…
- 濾胞性リンパ腫治療の世界市場（～2026年） Follicular lymphoma is a type of blood cancer. It is the most common of the indolent (slow-growing) non-Hodgkin's lymphomas, and the second-most-common form of non-Hodgkin's lymphomas overall. It is defined as a lymphoma of follicle center B-cells (centrocytes and centroblasts), which has at least a…
- 卵巣がん遺伝子治療の世界市場（～2026年） Ovarian cancer occurs and arises from several types of cells within the ovary, and it has the lowest survival rate of all gynecological cancers. Among many types, epithelial ovarian cancer (EOC) is the most common ovarian cancer, whereas ovarian low malignant potential tumor (OLMPT), germ cell tumor…
- 前立腺がんの世界市場（～2026年） Prostate cancer is cancer that occurs in the prostate. Market Analysis and Insights: Global Prostate Cancer Market The global Prostate Cancer market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Prostate Cancer Scope and Ma…